The effect of Porphyromonas gingivalis infection on cytokine levels in type 2 diabetic mice.
暂无分享,去创建一个
N. Sugano | K. Ito | Hajime Tanaka | S. Oka | M. Takano | R. Nishihara | T. Shimada | H. Tanaka
[1] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[2] D. Graves. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] A Mowat,et al. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. , 1971, The New England journal of medicine.
[4] W. Knowler,et al. Periodontal Disease and NIDDM in Pima Indians , 1990, Diabetes Care.
[5] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[6] M. Matsuda,et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and Biophysical Research Communications - BBRC.
[7] D. Graves,et al. Tumor Necrosis Factor Modulates Fibroblast Apoptosis, PMN Recruitment, and Osteoclast Formation in Response to P. gingivalis Infection , 2001, Journal of dental research.
[8] R. Mooney,et al. Interleukin-6 induces cellular insulin resistance in hepatocytes. , 2002, Diabetes.
[9] B. Mealey,et al. Diabetes mellitus and periodontal diseases. , 2006, Journal of periodontology.
[10] H. Iwatsuka,et al. General survey of diabetic features of yellow KK mice. , 1970, Endocrinologia japonica.
[11] T. Kadowaki,et al. Adiponectin and adiponectin receptors. , 2005, Endocrine reviews.
[12] R. Nagai,et al. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. , 2004, Biochemical and biophysical research communications.
[13] F. Nishimura,et al. Glucose-mediated Alteration of Cellular Function in Human Periodontal Ligament Cells , 1996, Journal of dental research.
[14] M. Kibata,et al. Relationship between serum tumor necrosis factor-α and insulin resistance in obese men with Type 2 diabetes mellitus , 2001 .
[15] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[16] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[17] A. Bascones-Martínez,et al. Effect of non-surgical periodontal therapy on clinical and immunological response and glycaemic control in type 2 diabetic patients with moderate periodontitis. , 2007, Journal of clinical periodontology.
[18] H. Löe. Periodontal Disease: The sixth complication of diabetes mellitus , 1993, Diabetes Care.
[19] T. Fukuda,et al. The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. , 2001, Journal of periodontology.
[20] R. Genco,et al. Periodontal disease in non-insulin-dependent diabetes mellitus. , 1991, Journal of periodontology.
[21] J. Pankow,et al. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. , 2003, Diabetes.
[22] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[23] R. Paschke,et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. , 2003, Biochemical and biophysical research communications.
[24] B. Spiegelman,et al. Adipsin and complement factor D activity: an immune-related defect in obesity , 1989, Science.
[25] A. Desfaits,et al. Normalization of Plasma Lipid Peroxides, Monocyte Adhesion, and Tumor Necrosis Factor-α Production in NIDDM Patients After Gliclazide Treatment , 1998, Diabetes Care.
[26] L. Kuller,et al. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. , 1996, American journal of epidemiology.
[27] R. Kent,et al. Clinical, microbiological and immunological profile of healthy, gingivitis and putative active periodontal subjects. , 1996, Journal of periodontal research.
[28] D. Graves,et al. Immunization Enhances Inflammation and Tissue Destruction in Response to Porphyromonas gingivalis , 2006, Infection and Immunity.
[29] N. Bissada,et al. Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. , 1981, Journal of periodontology.
[30] S. Socransky,et al. Microbial complexes in subgingival plaque. , 1998, Journal of clinical periodontology.
[31] J. Stewart,et al. Periodontal disease and diabetes mellitus , 2004, Current diabetes reports.
[32] T. Funahashi,et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. , 2001, Biochemical and biophysical research communications.
[33] J. Fernández-Real,et al. Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.
[34] H. Tilg,et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. , 2004, Biochemical and biophysical research communications.